Seeking Alpha

YMI
YM BioSciences Inc.

5/26/2012, 1:07 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
YMI Market Currents more »
  • February 22 YM Biosciences (YMI +6.3%) gets a boost from postitive comments out of Wells Fargo this morning, saying that recent weakness has created a buying a opportunity in the stock. Wells believes investors are failing to recognize the potential of the company's lead drug as both a treatment for myelofibrosis as well as other applications.
    Comment!
    [Healthcare, On the Move, Quick Ideas]
YMI in Focus more »
YMI News more »
YMI Latest Transcript more »
Currently, there are no transcripts for YMI.
YMI Cramer more »
Currently, there are no Cramer articles on YMI.
YMI Instablog posts more »
  • BRIC not likely to help Europe: Euro to weaken further
    Tue, Dec 13, 2011 • freefdawatchlist • Comment!
  • YM BioSciences Inc. (YMI) Reports Financial and Operational Results
    Mon, Nov 14, 2011 • MissionIR • Comment!
  • YM BioSciences Inc. (YMI) Reports Financial and Operational Results
    Mon, Nov 14, 2011 • QualityStocks • Comment!
  • YM BioSciences, Inc. (YMI) Begins Phase II Trial for Its CYT387 Drug
    Wed, Sep 28, 2011 • MissionIR • Comment!
  • Cancer research and treatment has interests
    Wed, Jul 21, 2010 • Jim Van Meerten • Comment!
Write a post on YMI
YMI StockTalks
YMI vs. ETF Alternatives
Company Description
Currently, there's no company description for YMI.
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: Canada